期刊文献+

地佐辛联合舒芬太尼在肝癌射频消融术后自控静脉镇痛的效果 被引量:10

下载PDF
导出
摘要 随着射频消融术的不断发展和推广,其已成为治疗肝癌的有效临床手段,但射频消融术创伤较大,因损伤和引流等因素造成术后疼痛较为剧烈,促使患者心率增快、耗氧增加,导致术后心血管相关并发症高,因此控制肝癌射频消融术的术后疼痛具有重要意义。舒芬太尼在临床上属于阿片类镇痛药,具有副作用小、选择性高、镇痛效果好等特点,目前已经被广泛应用于肝癌射频消融术后自控静脉(PCIA)镇痛中,
出处 《实用临床医药杂志》 CAS 2014年第9期181-182,共2页 Journal of Clinical Medicine in Practice
  • 相关文献

参考文献7

二级参考文献48

  • 1周军,孟凡民,周旭.芬太尼与可塞风在患者自控镇痛方面的应用[J].中国临床医学,2004,11(6):1118-1119. 被引量:6
  • 2佘守章.新型阿片类药物在病人自控镇痛中的应用[J].麻醉与监护论坛,2005,12(1):34-39. 被引量:39
  • 3骆璇,汪小海,徐鑫,崔苏扬,徐福涛.冠脉搭桥术病人红细胞包蔽吗啡溶液术后镇痛的可行性[J].中华麻醉学杂志,2005,25(6):410-413. 被引量:2
  • 4韦运杰,宫丽娅,苏秀宁,关小勇.利多卡因与布比卡因抑菌作用的临床研究[J].临床麻醉学杂志,2006,22(9):683-685. 被引量:15
  • 5Stahl KD, Van Bever W, Janssen P, et al. Receptor affinity and pharmacological potency of a series of narcotic analgesic antidiarrheal and ne μroleptic dr μgs. E μr J pharmacol, 1977,46: 199 -205.
  • 6Ahonen J, Olkkola KT, Hynynen M, et al. Comparison of alfentanil, fentanyl and s μfentanil for total intraveno μs anaesthesia with propofol in patients μndergoing coronary artery bypass s μrgery. Br J Anaesth ,2000,85:533-540.
  • 7Roth-Isigkeit A, Brechmann J, Dibbeh L, et al. Persistent endocrine stress response inpatients μndergoing cardiac s μrgery. J Endocrinol Invest, 1998,21 : 12-19.
  • 8Wilde MI Markham A, Ondam se trom : a review of its pham a cology and prelim inary clinical findings in novel applications. Dr μgs, 1996,52:773-794.
  • 9[3]Poopalalingam R,Chow MY,Wong LT.Patient-controlled epidural analgesia after thoracic and upper abdominal surgery using sufentanil with and without bupivacaine 0.125%[J].Singapore Med J,2003,44(3):126-30.
  • 10[5]Menigaux C,Guignard B,Fletcher D,et al.More epidural than intravenous sufentanil is required to provide comparable postoperative pain relief[J].Anesth Analg,2001,93(2):472-6.

共引文献858

同被引文献84

  • 1唐超峰,张玉鹏,李昭宇.原发性肝癌术后预防性肝动脉栓塞化疗的效果分析[J].宁夏医科大学学报,2013,35(5):575-577. 被引量:8
  • 2曾因明.现代麻醉学[M].北京:人民卫生出版社,2003:523-525.
  • 3覃怀成,孔勇.中晚期肝癌的TACE治疗进展[J].北方医药,2011,8(4):35-36.
  • 4吴新民,许幸,王俊科,王鲲鹏,薛张纲,缪长虹,邓小明,艾登斌,于浩.静脉注射右美托咪啶辅助全身麻醉的有效性和安全性[J].中华麻醉学杂志,2007,27(9):773-776. 被引量:242
  • 5Lau W Y, Lai E C. Hepatocellular carcinoma: current man- agement and recent advances[ J ]. Hepatobiliary Pancreat Dis Int, 2008, 7(3): 237.
  • 6Liapi E, Geschwind J F. Chemoembolization for primary and metastatic liver cancer[J]. Cancer J, 2010, 16(2) : 156.
  • 7Rice T W, Ruseh V W, Ishwaran H, et al. Cancer of the esophagus and esophagogastric junction: data- driven staging for the seventh edition of the American Joint Committee on Cancer/International Union Against Cancer CancerStaging Mmmals[J]. Cancer, 2010, 116(16): 3763.
  • 8Gao J, Hu Z, Wu J, et ai. Primary hepatic carcinoid tumor [J]. World J Surg Oneol, 2011; 9(5) : 151.
  • 9Zhou B, Shah H, Zhu K S, et al. Chemoembolization with lobaplatin mixed with iodized oil for unresectable recurrent hepatocellular carcinoma af*er ortholopic liver transplantation [J]. J Vasc lnterv Radiol, 2010, 21(3): 333.
  • 10Zhang Y J, Liang H H, Chen M S, et al. Hepatocellular Carcinoma Treated with Radiofrequency Ablation with or without Ethanol Injection: A Prospective Randomized Trial[J]. Radiology, 2007, 244(2): 599.

引证文献10

二级引证文献84

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部